News SinnoTest is supported by the regional AMI Tech Med program to further advance the SinnoTest on its regulatory path Sinnovial is laureate of the BPI France DeepTech grant Clinical Rheumatology publishes our research results on biomarkers predictive of the response to rituximab The first recruitments were registered in Spain in the multicentric clinical trial made possible thanks to the EIT Health Innovation by Ideas program Sinnovial laureate of the EIT Health “Innovation by Ideas” contest for its project of clinical and medico-economic evaluation of SinnoTest in Europe CE approval of SinnoTest: the biologics response prediction software developed by Sinnovial meets the relevant essential requirements of Directive 98/79 / EC on DM-DIV! Second scientific publication from Sinnovial in Joint Bone Spine journal Joint Bone Spine publishes the clinical results of the study BIORI Sinnovial, MedTech start-up highlighted in Présences magazine SinnoTest technology received a Seal of Excellence certificate delivered by the European Commission into the category of innovative SME in the “Healthcare and biotechnology” field Sinnovial, winner of the 2017 Innovation Prize in the Digitech area for SinnoTest technology
